wedrifid comments on A rationalist's guide to psychoactive drugs - Less Wrong Discussion
You are viewing a comment permalink. View the original post to see all comments and the full post content.
You are viewing a comment permalink. View the original post to see all comments and the full post content.
Comments (47)
What? This is wrong. GHB has a excessively steep dose-response curve and a terrible theraputic index. Enough so that GHB was the example the lecturer used in my pharmacology class when explaining what the theraputic index is and the risks of a bad one. It's about 2, which means that double the dose that gets you high can kill you. He went on to give details about the later stages of the synthesis of the end product (typically done a step or two closer to the final dealer) and how varying practices can lead to a variability in the delivered dose greater in magnitude than the theraputic index. This is bad.
My past self seems to have voted up the parent. I can only hope that is because he didn't read through fully. While most of the claims are true, the one that is wrong is a belief that gets people killed.
You have a cite for the LD50? Erowid gives 2000mg/kg for male rats and 1650mg/kg for female rats, and a strong dose of up to four grams for a human. I haven't seen any LD50 data for humans, but have read about people taking well over the normal dose, passing out, and waking up fine. It does seem to imply a therapeutic index well over two, and the comparison was made to alcohol which has a quite low one itself. Lethal BAC is around 0.4 and up to 0.2 is pretty common.
Mixing GHB with alcohol is a big no-no though, and does get people killed.
Pardon me. Cntrl-C failure. The link in the grandparent was supposed to be to the source but I evidently copied the wrong tab. In any case the measure was likely based on rats---there doesn't seem to be good data for humans. It also seems that the more 'official' (in social authority not academic authority) a source is the worse the drug is made to appear.
Further investigation brought up a few things worth mentioning: